Portfolio: Investments
Somaxon Pharmaceuticals, Inc.
Specialty pharmaceuticals for neurology and psychiatry
Surface Logix
Drugs for obesity, diabetes and cardiovascular diseases
Syndax Pharmaceuticals, Inc.
Novel combination regimens for cancer
Taigen Biotechnology Company, Ltd.
GPC receptor agonists and antagonists
Tercica, Inc.
Acquired by Ipsen
Theraclone Sciences
Novel tumor-specific therapeutic antibodies





